PD 157 40 (Lipitor 40 mg)
Generic Name: atorvastatin
Pill imprint PD 157 40 has been identified as Lipitor 40 mg.
Lipitor is used in the treatment of high cholesterol; prevention of cardiovascular disease; high cholesterol, familial heterozygous; high cholesterol, familial homozygous; hyperlipoproteinemia type iii, elevated beta-vldl idl (and more), and belongs to the drug class statins. Not for use in pregnancy. Lipitor 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PD 157 40
- Generic Name:
- 40 mg
- 15.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium carbonate
hydroxypropyl cellulose (type h)
|NDC Code||Manufacturer / Repackager|
|54569-4587||A S Medication Solutions LLC (repackager)|
|68258-6002||Dispensing Solutions Inc. (repackager)|
|67544-0247||Prepak Systems Inc (repackager)|
|13411-0114||Advanced Pharmaceutical Services Inc (repackager)|
|55289-0861||PDRX Pharmaceuticals Inc (repackager)|
|49999-0468||Lake Erie Medical and Surgical Supply (repackager)|
|68258-9154||Dispensing Solutions Inc. (repackager)|
|63874-0319||Altura Pharmaceuticals Inc (repackager)|
|68115-0668||Dispensexpress Inc (repackager)|
|52959-0046||H.J. Harkins Company, Inc (repackager)|
|23490-0132||Palmetto State Pharmaceuticals Inc (repackager)|
|54868-4229||Physicians Total Care Inc (repackager)|
|68071-0310||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about Lipitor (atorvastatin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.